Company / Operating Cash Flow per Share
Crinetics Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.95
FY2025
5-year range
-$3.95 / -$1.86
FY2021-FY2025
Trend
-59.6%
vs FY2024
Sector context
#188 of 212
Health Care
What the data says
Crinetics Pharmaceuticals, Inc.'s operating cash flow per share of $-3.95 is lower than 89% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-393.96 in FY2019 to $-0.80 in FY2020.
Based on SEC 10-K filings.
-3.95 in FY2025.
Declined from $-2.90 to $-3.95 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+73.1% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 59.6% year-over-year.
- Ranks #188 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.95 | -59.6% |
| FY2024 | -$2.48 | +14.7% |
| FY2023 | -$2.90 | -35.8% |
| FY2022 | -$2.14 | -14.9% |
| FY2021 | -$1.86 | -132.1% |
| FY2020 | -$0.80 | +99.8% |
| FY2019 | -$393.96 | -11064.3% |
| FY2018 | -$3.53 | +49.0% |
| FY2017 | -$6.91 | -27.8% |
| FY2016 | -$5.41 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026